Search in:

OncoImmunology Volume 9, 2020 - Issue 1

Submit an article Journal homepage

Open access

1,927

Views

CrossRef citations to date

Altmetric

Research Article

Progesterone receptor promotes degradation of STAT2 to inhibit the interferon response in breast cancer

Katherine R. Waltera Department of Biochemistry and Molecular Biology, Department of Cancer Biology, University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USAView further author information

Justin M. Balkob Departments of Medicine and Pathology, Microbiology, and Immunology, and Breast Cancer Research Program, Vanderbilt University Medical Center, Nashville, TN, USAView further author information

Christy R. Hagana Department of Biochemistry and Molecular Biology, Department of Cancer Biology, University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USACorrespondence[email protected]

https://orcid.org/0000-0003-2524-1815 View further author information

Article: 1758547 | Received 26 Nov 2019, Accepted 03 Apr 2020, Published online: 30 Apr 2020

Cite this article
https://doi.org/10.1080/2162402X.2020.1758547
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (11)

Tianchu Wang, Ryan T. Wagner, Ryan A. Hlady, Xiaoyu Pan, Xia Zhao, Sungho Kim, Liguo Wang, Jeong‐Heon Lee, Huijun Luo, Erik P. Castle, Douglas F. Lake, Thai H. Ho & Keith D. Robertson. (2023) SETD2 loss in renal epithelial cells drives epithelial‐to‐mesenchymal transition in a TGF ‐β‐independent manner . Molecular Oncology 18:1, pages 44-61.
Crossref

Mary A. Oliver, Katie D. Peterson, Sadikshya Bhandari, Rebecca R. Payton, J. Lannett Edwards & Daniel J. Mathew. (2023) Progesterone-stimulated endometrial cell conditioned media increases in vitro produced bovine embryo blastocyst formation. Animal Reproduction Science 254, pages 107264.
Crossref

HyeonJoo Cheon, Yuxin Wang, Samantha M. Wightman, Mark W. Jackson & George R. Stark. (2023) How cancer cells make and respond to interferon-I. Trends in Cancer 9:1, pages 83-92.
Crossref

Jorge Canar, Kennedy Darling, Ryan Dadey & Ana M. Gamero. (2023) The duality of STAT2 mediated type I interferon signaling in the tumor microenvironment and chemoresistance. Cytokine 161, pages 156081.
Crossref

Juyeong Hong, Ji Hoon Lee, Zhao Zhang, Yanming Wu, Mei Yang, Yiji Liao, Richard de la Rosa, Jessica Scheirer, Douglas Pechacek, Nu Zhang, Zhenming Xu, Tyler Curiel, Xi Tan, Tim H.-M. Huang & Kexin Xu. (2022) PRC2-Mediated Epigenetic Suppression of Type I IFN-STAT2 Signaling Impairs Antitumor Immunity in Luminal Breast Cancer. Cancer Research 82:24, pages 4624-4640.
Crossref

Grace L. Wong, Sara G. Manore, Daniel L. Doheny & Hui-Wen Lo. (2022) STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges. Seminars in Cancer Biology 86, pages 84-106.
Crossref

Felix Ruoff, Nicolas Kersten, Nicole Anderle, Sandra Jerbi, Aaron Stahl, André Koch, Annette Staebler, Andreas Hartkopf, Sara Y. Brucker, Markus Hahn, Katja Schenke-Layland, Christian Schmees & Markus F. Templin. (2022) Protein Profiling of Breast Carcinomas Reveals Expression of Immune-Suppressive Factors and Signatures Relevant for Patient Outcome. Cancers 14:18, pages 4542.
Crossref

Valentina Scabia, Ayyakkannu Ayyanan, Fabio De Martino, Andrea Agnoletto, Laura Battista, Csaba Laszlo, Assia Treboux, Khalil Zaman, Athina Stravodimou, Didier Jallut, Maryse Fiche, Philip Bucher, Giovanna Ambrosini, George Sflomos & Cathrin Brisken. (2022) Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor. Nature Communications 13:1.
Crossref

Xiaoyong Fu, Carmine De Angelis & Rachel Schiff. (2022) Interferon Signaling in Estrogen Receptor–positive Breast Cancer: A Revitalized Topic. Endocrinology 163:1.
Crossref

Taylor E. Escher, Prasad Dandawate, Afreen Sayed, Christy R. Hagan, Shrikant Anant & Joan Lewis-Wambi. (2021) Enhanced IFNα Signaling Promotes Ligand-Independent Activation of ERα to Promote Aromatase Inhibitor Resistance in Breast Cancer. Cancers 13:20, pages 5130.
Crossref

Lauryn R Werner, Katelin A Gibson, Merit L Goodman, Dominika E Helm, Katherine R Walter, Sean M Holloran, Gloria M Trinca, Richard C Hastings, Howard H Yang, Ying Hu, Junping Wei, Gangjun Lei, Xiao-Yi Yang, Rashna Madan, Alfredo A Molinolo, Mary A Markiewicz, Prabhakar Chalise, Margaret L Axelrod, Justin M Balko, Kent W Hunter, Zachary C Hartman, Carol A Lange & Christy R Hagan. (2021) Progesterone promotes immunomodulation and tumor development in the murine mammary gland. Journal for ImmunoTherapy of Cancer 9:5, pages e001710.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Progesterone receptor promotes degradation of STAT2 to inhibit the interferon response in breast cancer

Articles from other publishers (11)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Progesterone receptor promotes degradation of STAT2 to inhibit the interferon response in breast cancer

Citations (11)

Articles from other publishers (11)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date